Wednesday, July 8, 2026

pharma · Alzheimer's Disease · Type 2 Diabetes Mellitus · VTVT

vTv Therapeutics

vTv Therapeutics patent portfolio — 50 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US HQ
55 Employees
Public company Type
VTVT · NYSE Ticker
Company details
Status
Public
HQ
3980 Premier Dr, Suite 110, High Point, North Carolina 27265, US
Employees
55
Programs
14
Drugs
2
Patents
50
Intelligence · Patents

vTv Therapeutics patents

50 pharmaceutical patents indexed for vTv Therapeutics. 0 expire within 24 months.

vTv Therapeutics has 50 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

Page 2 of 2
  1. US 9163022

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 9120813

    Oxadiazoanthracene compounds for the treatment of diabetes

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does vTv Therapeutics have?

50 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do vTv Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.